Fotivda (tivozanib) is a targeted therapy for treating advanced kidney cancer (renal cell carcinoma). Fotivda (tivozanib) isn't a first-choice treatment, but typically only prescribed if the cancer comes back after or didn’t respond well to previous treatments. Fotivda (tivozanib) is taken by mouth once a day. Some of the more common side effects of this medication include tiredness, diarrhea, and a lowered appetite.
Fotivda (tivozanib) is a targeted therapy known as a tyrosine kinase inhibitor (TKI). More specifically, it blocks vascular endothelial growth factor receptors (VEGFRs). These are proteins in cancer cells that provide blood supply to the tumor. By blocking these proteins, Fotivda (tivozanib) prevents blood vessels from forming and supplying blood to the tumor. This helps to slow and stop cancer growth.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
No, Fotivda (tivozanib) isn't considered chemotherapy. Chemotherapy is a class of medications that kills fast-growing cells in your body, such as cancer cells. But Fotivda (tivozanib) is a type of targeted therapy called a tyrosine kinase inhibitor (TKI). It works differently than chemotherapy because it targets specific proteins on cancer cells that play a role in blood supply and tumor growth. In doing so, Fotivda (tivozanib) cuts off blood supply to the tumor, which slows cancer growth.
Yes, Fotivda (tivozanib) can cause dysphonia, which is hoarseness or weakness of the voice. About 20% of the people who took Fotivda (tivozanib) in clinical studies experienced this side effect. If you’re bothered by the voice changes or have trouble speaking, let your healthcare provider know and they can talk with you about your options.
People who take Fotivda (tivozanib) commonly have diarrhea as a side effect. If you experience this, it’s important to stay well-hydrated to prevent your body from losing too much fluid and electrolytes. To help ease diarrhea, you can try making changes to your diet to avoid fatty, fried, or fibrous foods that might make diarrhea worse. You can try a bland diet with foods like bananas, rice, and toast. Ask your provider if it's appropriate to take over-the-counter (OTC) antidiarrheal medications, such as loperamide (Imodium), to slow down movement through the intestines. Let your healthcare provider know if you have diarrhea that’s difficult to control because you might need more medical attention.
Let your provider know if you have liver problems before starting Fotivda (tivozanib). If you have liver problems, your healthcare provider might need to lower your dose of Fotivda (tivozanib). But if you have serious liver problems, your provider will likely talk with you about other treatment options.
You should avoid breastfeeding while taking Fotivda (tivozanib). We don’t know if it can pass into human breast milk, but there’s a risk of serious harm to nursing infants if it does. Because of this risk, you shouldn’t breastfeed while taking Fotivda (tivozanib) and for at least 1 month after your last dose. Talk with your provider about other ways to feed your baby during treatment.
Fotivda (tivozanib) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Fotivda (tivozanib) can raise your blood pressure, sometimes to dangerously high levels. Some people experienced this within 2 weeks of starting treatment. Your provider will only let you start Fotivda (tivozanib) after your blood pressure is under control. Once you start treatment, they’ll check your blood pressure 2 weeks later and then monthly after that. If your blood pressure starts to rise, your provider might ask you to start blood pressure-lowering medications. If your blood pressure becomes dangerously high, your provider will likely ask you to stop Fotivda (tivozanib) or lower your dosage. Let your provider know if you notice symptoms of dangerously high blood pressure, such as dizziness, confusion, and headaches.
Rarely, Fotivda (tivozanib) can cause heart failure. If so, your provider might recommend that you stop taking this medication (temporarily or permanently) or lower your dosage, depending on how severe it is. To lower your risk of a serious problem, your provider might order an echocardiogram before you start Fotivda (tivozanib) and check you for heart failure symptoms regularly during treatment. Let your provider know right away if you have symptoms like chest pain, trouble breathing, swelling in lower legs or feet, feeling faint or lightheaded, or tiredness.
Fotivda (tivozanib) can raise your risk for blood clots. Blood clots can form anywhere in your body, including brain (stroke) and heart (heart attack). If you develop a blood clot, your healthcare provider might ask you to stop treatment with Fotivda (tivozanib), depending on how serious. Symptoms of a blood clot might be different depending on the location of the clot. Get medical attention right away if you have any symptoms of blood clots, including trouble walking, blurry vision, breathing problems, chest pain, and swelling in the leg.
Fotivda (tivozanib) can raise the risk of serious bleeding, which can be life-threatening. Bleeding can happen in any area of the body, including in the lungs, stomach, and brain. If you experience serious bleeding, your healthcare provider might ask you to stop Fotivda (tivozanib) completely.
Get medical help right away if you experience any serious or unusual bleeding, especially bleeding that’s difficult to stop. Also, get medical attention immediately if you have symptoms of bleeding on the inside of your body, such as nausea, sudden or painful headache, changes in your vision, stomach pain, or are coughing or spitting up blood.
Though not common, Fotivda (tivozanib) can raise the risk of kidney injuries. Most of the time, people don’t feel any symptoms, but their labs will show higher protein levels in the urine. To be safe your provider will monitor your kidney health through lab work and by taking urine samples before and while you’re receiving this medication. If you develop kidney problems, your provider might pause or lower your dosage of Fotivda (tivozanib) until your kidney gets better, or permanently discontinue the medication, depending on the severity. Talk to your provider if you notice any changes in how often you urinate (more or less) or any blood in your urine so they can check for kidney issues.
Fotivda (tivozanib) can cause thyroid problems like hypothyroidism and hyperthyroidism. Symptoms of thyroid gland problems can include weight loss or weight gain, feeling nervous or anxious, depression, eye or neck swelling, feeling hot or cold, sweating, or changes in menstruation.
Let your healthcare provider know if you have symptoms of thyroid gland problems. They will order lab tests before and during treatment to check your thyroid health. If appropriate, they might start you on thyroid replacement medication.
Fotivda (tivozanib) can make it more difficult for your wound to heal. Let your provider know if you’re planning to have a surgery or procedure, including dental surgery. You shouldn’t take Fotivda (tivozanib) for 24 days before and at least 2 weeks after surgery, and until surgical wounds have fully healed.
PRES is a very rare side effect of Fotivda (tivozanib). If you develop symptoms, your provider will order a brain scan called a magnetic resonance imaging (MRI) to check for RPLS. If you do have this condition, then it’s very likely that your provider will ask you to stop Fotivda (tivozanib) treatment. Let your provider know if you have any symptoms of RPLS, like headache, seizures, confusion, vision changes, or difficulty thinking.
Fotivda (tivozanib) can cause harm to an unborn baby. If you're a female who’s able to become pregnant, your provider might ask you to take a pregnancy test before you start treatment. Males and females who are taking Fotivda (tivozanib) should use effective birth control while taking Fotivda (tivozanib) and for 1 month after the last dose. Let your provider know right away if you or your partner become pregnant during this time.
The 0.89 mg capsule of Fotivda (tivozanib) contains a dye called tartrazine, also known as FD&C Yellow No.5. This dye can cause an allergic reaction, including trouble breathing, in some people. The risk of this is generally low, but might be higher in people who also have an allergy to aspirin.
The typical dose of Fotivda (tivozanib) is 1.34 mg by mouth once daily for 21 days out of a 28-day treatment cycle, followed by 7 days off treatment.
This dose might differ if you have liver problems.